Clinical Trial Update: PoC Study of OBE022 in Threatened Preterm Labour [Phase 2]

View source ↗

Summary

Phase 2 PoC study update for OBE022 in threatened preterm labour; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Labor

Drugs mentioned

• OBE022

Snippet

Sponsor: ObsEva SA | Conditions: Preterm Labor | Phase 2 | Status: UNKNOWN